Eastwood Bio-Medical Canada Inc. (TSXV: EBM)

Market Cap	46.84M
Revenue (ttm)	653.54K
Net Income (ttm)	-484.16K
Shares Out	68.89M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Open	0.680
Previous Close	0.980
Day's Range	0.680 - 0.680
52-Week Range	0.280 - 1.150
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 27, 2025

About EBM

Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company’s licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and goo...

• Industry: Food Distribution
• Sector: Consumer Staples
• Founded: 2010
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: EBM

Financial Performance

In 2023, EBM's revenue was 867,936, a decrease of -33.22% compared to the previous year's 1.30 million. Losses were -546,598, 264.7% more than in 2022.